5 Penny Stocks Insiders Are Buying

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

LiveOne

• The Trade: LiveOne, Inc. LVO CEO and Chairman Robert S Ellin acquired a total of 10000 shares at an average price of $2.30. The insider spent $22,959.00 to buy those shares.
• What’s Happening: LiveOne recently reported a media partnership with Empire Media Group for an eight-figure, multi-year deal.
• What LiveOne Does: LiveOne Inc, formerly LiveXLive Media Inc is the premium internet networks devoted to live music and music-related video content.

Recro Pharma

• The Trade: Recro Pharma, Inc. REPH CEO David Enloe Jr acquired a total of 1725 shares at an average price of $1.68. The insider spent $2,895.24 to buy those shares.
• What’s Happening: The company recently posted upbeat quarterly sales.
• What Recro Pharma Does: Recro Pharma Inc is a contract development and manufacturing company. The company is engaged in the development, formulation, regulatory support, manufacturing, and packaging of oral solid dose drug products.

Live Current Media

• The Trade: Live Current Media Inc. LIVC Director Amir Vahabzadeh acquired a total of 173210 shares at an average price of $0.33. To acquire these shares, it cost $56,849.22.
• What’s Happening: Live Current, last month, signed a new marketing agreement with Think Ink Marketing.
• What Live Current Media Does: Live Current Media Inc is a digital technology company involved in the entertainment industry. Currently, the company is developing two projects, SPRT MTRX for App Store and Play Store and Boxing.com FEDERATION.

Cidara Therapeutics

• The Trade: Cidara Therapeutics, Inc. CDTX President and CEO Jeffrey Stein acquired a total of 50000 shares shares at an average price of $1.59. The insider spent $79,530.00 to buy those shares.
• What’s Happening: Cidara Therapeutics recently posted a Q3 loss of $0.37 per share.
• What Cidara Therapeutics Does: Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases.

ARC Document Solutions

• The Trade: ARC Document Solutions, Inc. ARC Director Mark Mealy acquired a total of 20000 shares shares at an average price of $3.08. The insider spent $61,536.50 to buy those shares.
• What’s Happening: The company recently reported Q3 results.
• What ARC Document Solutions Does: ARC Document Solutions Inc is a global document solutions provider. The company's service offerings include managed print services (MPS), offsite services, archive and information management ( AIM), specialized color printing, Web-based document management applications, and equipment and supplies sales.